INS and type 2 diabetes mellitus: In seven (20%) patients, hyperglycemia development was insidious and was initially managed as NIDDM; in these cases, however, glucose levels were poorly controlled despite the optimization of oral anti-diabetic agents, and adequate diabetes control was only achieved after the introduction of insulin replacement therapy.